SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-12-000143
Filing Date
2012-05-14
Accepted
2012-05-14 17:27:08
Documents
1
Group Members
ABINGWORTH BIOVENTURES IV EXECUTIVES LPABINGWORTH BIOVENTURES IV LP

Document Format Files

Seq Description Document Type Size
1 SUPERNUS PHARM 13D supernus13dmay12.htm SC 13D 236932
  Complete submission text file 0000905718-12-000143.txt   238368
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 20 7534 1508
Abingworth Management LTD (Filed by) CIK: 0001291892 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Subject) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-86843 | Film No.: 12839915
SIC: 2834 Pharmaceutical Preparations